Association between ADHD medication history and stimulant misuse in adolescents

Natalia Gass

DOI: https://doi.org/10.1038/s44220-023-00070-8

2023-05-11

Nature Mental Health

Abstract:To examine these links, Schepis et al. conducted a multi-cohort cross-sectional study on 199,560 adolescents (aged 13–19) using school-based nationally representative data collected between 2005 and 2020 from the US Monitoring the Future survey, led by the National Institute on Drug Abuse at the National Institutes of Health. The researchers grouped participants by pharmacotherapy history into four categories: (1) no pharmacotherapy; (2) stimulant only; (3) non-stimulant only; and (4) both stimulant and non-stimulant medications. They found that adolescents who took both stimulant and non-stimulant medications had the highest rates of past-year PSM (22.3%), cocaine use (10.4%) and methamphetamine use (7.8%), whereas adolescents who had not received pharmacotherapy had the lowest rates (4.7%, 1.6% and 0.7%, respectively). The two monotherapy groups had lower rates of PSM and substance use. "We believe that the elevated risk in those who have a history of both stimulant and non-stimulant treatment is probably due to greater ADHD symptom severity, the psychosocial sequelae of ADHD, accompanying psychiatric comorbidity, and/or a history of ADHD treatment failure — not the treatment itself," explains Ty Schepis, first author of the paper. Consistent with previous studies, individuals with a presumed ADHD diagnosis had significantly higher rates of PSM, cocaine use and methamphetamine use. "What this research added was two key findings: first, there was no difference between monotherapy groups; and second, adolescents with a history of both stimulant and non-stimulant medication use represent a particularly high-risk group," adds Schepis. These results call for action to establish an ongoing screening for substance use with instruments that cover a wide range of substances in those adolescents who are prescribed medication for ADHD.